Direct acting antiviral - Globe Thesis

Keyword [Direct acting antiviral] Result: 1 - 17 \| Page: 1 of 1
1.	Impact Of Virus Specific T Cell Responses On Chronically HCV-1b Infected Patients Receiving Interferon-Free Direct-Acting Antiviral Agents(DAAs)Therapy
2.	The Prevalence Of Pre-existing HCV Variants Resistant To Direct-acting Antiviralagents And Epidemiology And Treatment Of HCV Infection
3.	Efficacy Of Direct-acting Antiviral Agents In Treatment Of Hepatitis C Cirrhosis
4.	Prevalence Of HCV Resistant Association Substitutions To Direct-Acting Antiviral Agents In Treatment-Na?ve HCV Genotype 1b Infected Patients In Western China
5.	Study On Genetic Drug Resistance Polymorphism In NS5B Region Of Hepatitis C Virus
6.	Analysis Of Naturally Occurring Resistance-associated Variants To NS5A Inhibitors In Patients With Chronic Hepatitis C In Guangxi
7.	Efficacy And Safety Of Direct-acting Antiviral Agents In Treatment Of Hepatitis C Cirrhosis
8.	Systematic Evaluation And Meta-analysis Of The Incidence Of Liver Cancer In Patients With Hepatitis C Treated With Interferon And Direct Antiviral Drugs
9.	Characteristic And Its Implication Of Natural Killer Cells In Chronic Hepatitis C Patients Cured With Direct-Acting Antiviral Agents
10.	The Efficacy Of Direct-Acting Antiviral Agents In Real World And The Diseases Progression And Clinical Outcomes Of Chronic Hepatitis C With Anti-Viral Treatments
11.	Epidemiological Characteristics Of Patients With Genotype 3 Hepatitis C And Efficacy And Safety Of DAAs
12.	A Long-term Clinical Study Of Virological And Hepatic Benefits Of Patients With Chronic Hepatitis C Virus Infected After DAA Treatment
13.	Metabolic Disorders Induced By PNPLA3 And TM6SF2 Gene Variants Affect CKD And The Prognosis Of Kidney Injury After DAA In Chronic HCV Infection
14.	Study On The Primary Drug Resistance Mutation Of Hepatitis C Virus In Chinese Voluntary Blood Donors And The Mechanism Of S Protein Transmembrane Domain Mutation Affecting The Occurrence And Development Of Latent Hepatitis B Virus Infectio
15.	Hepatitis B Virus Reactivation In Patients Treated With Direct Acting Antiviral For HCV/HBV Co-infection: A Meta-analysis And Clinical Observation
16.	Evaluation Of The Long-term Efficacy Of DAA Drugs In Treating HCV Infected Individuals After Achieving SVR
17.	The Efficacy And Safety Of Direct-acting Antivirals Drugs In Children And Adolescents With Chronic Hepatitis C Virus Infection:A Meta-analysis
<<First <Prev Next> Last>> Jump to